NantPharma currently manufactures and markets crude heparin in a concentrated eluate form, processed from porcine intestinal mucosa collected exclusively from slaughterhouses in the United States and Europe.


NantWorks acquires Cynviloq™ for up to $1.3 billion —$90 million+ up-front payment and $1.2 billion+ milestone payments.

Our Facilities

NantPharma is headquartered in Rolling Meadows, Illinois. Other locations include a research and development laboratory in the Chicagoland area, as well as a manufacturing facility in the Midwest.